Literature DB >> 11697644

Primary cutaneous follicle center cell lymphoma.

L Cerroni1, H Kerl.   

Abstract

The exact classification of primary cutaneous follicle center cell lymphomas (FCCLs) has been the subject of ongoing debate. In the classification of cutaneous lymphomas proposed by the European Organization for Research and Treatment of Cancer (EORTC)-Cutaneous Lymphoma Project Group, cutaneous follicle center cell lymphoma (FCCL) is defined as a proliferation of centrocytes and centroblasts showing a diffuse pattern of growth in the great majority of cases, and presenting only rarely a true follicular pattern. CD10 and Bcl-2 are usually not expressed by neoplastic cells, and the t(14:18) is absent. By contrast, nodal follicular lymphoma is a tumor with a follicular pattern, characterized by the proliferation of CD10+, Bcl-2+ follicular cells, and by the presence of the t(14;18) in most cases. In this review we outline the clinicopathologic, phenotypic, and molecular features of primary cutaneous FCCL, reviewing criteria for diagnosis and differential diagnosis of this peculiar variant of cutaneous B-cell lymphoma.

Entities:  

Mesh:

Year:  2001        PMID: 11697644     DOI: 10.3109/10428190109097708

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Primary dural low grade BCL-2 negative follicular lymphoma: a case report.

Authors:  Sushil Beriwal; J Steve Hou; Curtis Miyamoto; Jorge A Garcia-Young
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

2.  Transformation of a cutaneous follicle center lymphoma to a diffuse large B-cell lymphoma-an unusual presentation.

Authors:  J Dias Coelho; F Diamantino; I Costa; P Farinha; P Gameiro; M Sebastião; J Baptista
Journal:  Case Rep Med       Date:  2010-05-31

3.  Primary Cutaneous Follicle Centre Lymphoma with Hodgkin and Reed-Sternberg Like Cells: A Case Report and Review of the Literature.

Authors:  Fatima A Aldarweesh; Diana O Treaba
Journal:  Case Rep Hematol       Date:  2017-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.